Healthcare, Pharma, Medical Device etc.
Category
United states of America
Geographic Coverage
Not Available
Video URL
Not Available
Sale price (USD)
Not Available
Non-exclusive license price (USD)
Not Available
Exclusive license price (USD)
Not Available
Non-exclusive license royalty rate %
Availability
Patent family
Number of members in the patent family
Assignee(s) / Patent owner(s)
To see the additional information details please login and subscribe to a Premium account.

Electrospinning for use in tissue engineering

Patent Granted Medical[edit] Artificial organ components Tissue engineering.[38] Living cells can be co-deposited with electrospun material.[39] Endogenous Tissue Growth (ETG) is a therapeutic category in which surgeons use synthetic biodegradable implants designed to allow the body to repair itself by spontaneously growing natural, healthy tissue from the inside. The principle of Endogenous Tissue Growth is to use of the host response to trigger a remodeling process and by ensuring the material degrades in time, the host response is resolved in time as well. When the material is fully degraded, the architecture is remodeled into a well developing structure. It is characterized by the key features of a native cardiovascular structure containing collagen, elastin, myofibroblasts, endothelial cells and blood vessels.

GET LICENSE BROKER APPLY submit an inquiry
photo To see the additional information details please login and subscribe to a Plus or Premium account.